Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study-Reference-Cited by-同舟云学术

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study

Published:2015-11 Issue:46 Volume:33 Page:6351-6359
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Rupp Richard,Luckasen Gary Joseph,Kirstein Judith Lee,Osorio Jorge E.,Santangelo Joseph D.,Raanan Marsha,Smith Mary Kathryn,Wallace Derek,Gordon Gilad S.,Stinchcomb Dan T.

Publisher

Elsevier BV

Reference20 articles.

1. Dengue: guidelines for diagnosis, treatment, prevention and control;World Health Organization,2009

2. The global distribution and burden of dengue;Bhatt;Nature,2013

3. The burden of dengue infection;Halstead;Lancet,2007

4. Global Strategy for dengue prevention and control, 2012–2020;WHO,2012

5. The dengue vaccine pipeline: Implications for the future of dengue control;Schwartz;Vaccine,2015

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAK-003: development of a tetravalent dengue vaccine;Expert Review of Vaccines;2025-04-25

2. Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis;Vaccines;2024-07-13

3. Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination;The Journal of Infectious Diseases;2024-04-29

4. CD4+ T Cell Depletion Before Primary Dengue and/or Secondary Zika Infection Reveals Mechanistic Correlates of Antibody Functionality in Rhesus Macaques;2024-02-22

5. Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination;Cell Host & Microbe;2023-11